News
4 Certificates to Build a Successful Medical Aesthetics Practice Through Proper Training
The aesthetics industry is becoming a more popular career path for people with medical backgrounds. If you would also like to explore those services, you’ll need training to provide them safely. We partnered with The American Association of Aesthetic...
News
How In-Home Care Is Transforming Patient Support in Major U.S. Cities
The move toward in-home care is driven by various demands, primarily the desire for comfort and the health care industry’s need for better outcomes. When seniors have professional support at home, it may translate to better treatment adherence and...
News
Improving Volunteer Management in Healthcare With Smart Scheduling Tools
Volunteer programs are the backbone of health care organizations. They support staff, comfort patients and keep organizations running smoothly in ways that often go unnoticed. Yet, managing these volunteers is a complex undertaking. We partnered with Volgistics to bring...
Business & Industry
Lilly, Insilico Sign $2.75B AI Drug Discovery Collaboration
Eli Lilly has expanded its engagement with Insilico Medicine, formalising a new AI drug discovery collaboration valued at up to $2.75 billion, further extending a relationship that began with an AI software licensing agreement in 2023. The latest agreement...
Business & Industry
Daiichi Sankyo Enter AI Oncology Collaboration with Tempus
Daiichi Sankyo has formalised a strategic agreement with Tempus AI aimed at accelerating the clinical trajectory and differentiation of an antibody drug conjugate programme within oncology. The collaboration centres on integrating advanced AI capabilities into drug development workflows, with...
Business & Industry
FDA Seeks Input on National Priority Voucher Pilot Program
The U.S. Food and Drug Administration has initiated a new phase of stakeholder engagement for its national priority voucher pilot program, announcing a public meeting scheduled for June 12, 2026, alongside a Federal Register Notice seeking industry feedback. The...
Business & Industry
Merck Acquires Terns Pharmaceuticals in $6.7 Billion Deal
Merck, known as MSD outside the United States and Canada, confirmed it has signed a definitive agreement to acquire Terns Pharmaceuticals in a deal valued at approximately $6.7 billion. The transaction, priced at $53.00 per share in cash, has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read